Published on in Vol 9, No 5 (2020): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17603, first published .
An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study

An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study

An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study

Neil William Douglas Thomas   1, 2, 3, 4 , BSc, MD, MSc ;   Zachary Beattie   3 , PhD ;   Jennifer Marcoe   3 , MA ;   Kirsten Wright   3 , ND, MCR, MSc ;   Nicole Sharma   3 , BSc ;   Nora Mattek   3 , MPH ;   Hiroko Dodge   3, 5 , PhD ;   Katherine Wild   3 , PhD ;   Jeffrey Kaye   3, 4 , MD

1 Bruyère Research Institute, Ottawa, ON, Canada

2 Department of Medicine, University of Ottawa, Ottawa, ON, Canada

3 Department of Neurology, Oregon Health and Science University, Portland, OR, United States

4 Department of Neurology, Department of Veterans Affairs, VA Medical Center, Portland, OR, United States

5 Department of Neurology, University of Michigan, Ann Arbor, MI, United States

Corresponding Author:

  • Neil William Douglas Thomas, BSc, MD, MSc
  • Bruyère Research Institute
  • 43 Bruyère St.
  • Ottawa, ON, K1N 5C8
  • Canada
  • Phone: 1 6135626322
  • Fax: 1 6135626013
  • Email: nthomas@bruyere.org